"Large Banks" CMB International's Investment Ratings and Target Prices for Chinese Pharmaceutical Stocks (Table)

AASTOCKS
2025.11.11 03:06

Zhao Yin International published a research report, listing the investment ratings and target prices for Chinese pharmaceutical stocks as follows:

Stock | Investment Rating | Target Price (HKD)

3SBIO (01530.HK) | Buy | 37.58

GUSHENGTANG (02273.HK) | Buy | 48.28

GIANT BIOGENE (02367.HK) | Buy | 58.35

WUXI XDC (02268.HK) | Buy | 74

INNOVENT BIO (01801.HK) | Buy | 110.62

SINO BIOPHARM (01177.HK) | Buy | 9.4

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer